A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
|Articles|February 1, 2009
- Volume 0 0
7 Deadly Sins: Interviews
Advertisement
- Arriving late—Set 2 alarm clocks, and allow more than enough travel time.
- Dressing informally—Have a dry-cleaned, conservative business suit ready to go.
- Poor eye contact—Concentrate on maintaining eye contact throughout the interview. Eye contact is not the same as staring.
- Asking only self-serving questions—Prepare questions that show your interest in the position or company.
- Demonstrating ignorance about the hiring company—Do some background research on the company before the interview.
- Using everyday language and speech patterns—Practice interviewing and using professional terminology where appropriate. Avoid "like," "ya know," "really," and "OK?" when they are simply fillers.
- Failing to address the question asked—Be careful to listen to the question and understand it before answering.
Articles in this issue
over 17 years ago
Dr. Tom's Top 10 Tips: Passing the Pharmacy Boardsover 17 years ago
The Next Generation of Pharmacy Practiceover 17 years ago
Endless Opportunities in the Pharmaceutical Industryover 17 years ago
Q&A: Perspective from a Specialty Pharmacy Veteranover 17 years ago
Career Connectionsover 17 years ago
Behind the Bench: Inside Kmart's Pharmacy Serviceover 17 years ago
Mayo's Diversity of Practice Appealing to Pharmacistsover 17 years ago
VA: Rewarding Opportunities and Room to Growover 17 years ago
7 Deadly Sins: R?sum?over 17 years ago
Pharmacists Empowered at Supermarket ChainsAdvertisement
Related to this article
A Novo Nordisk-funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, though the findings cannot show causation.
Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
A retrospective study from Japan found that oncology pharmacist assessment before medical examination was associated with higher rates of complete adverse event resolution in outpatient chemotherapy.
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
September’s pain management coverage examined postoperative nonopioid options, lessons from sickle cell pain research, and pharmacists’ experiences with controlled-substance prescribing.
September’s hematology coverage examined a new definition of myeloma cure, patient preferences for treatment delivery, and emerging strategies for deepening responses.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
3
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
4
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
5